| John O'Grady is Medical Director for Europe, Daiichi Pharmaceuticals UK Ltd, a director of Imperial Cancer Research Technology Ltd, Visiting Professor of Clinical Pharmacology and Therapeutics, University of Vienna, Austria and Visiting Professor of Clinical Pharmacology, University of London. He is examiner to the Royal College of Physicians and external examiner, University of Guildford, Surrey. He has published widely in the field of medicine and in clinical pharmacology and therapeutics and is editor of several books dealing with drug effects in man including the Textbook of Pharmaceutical Medicine and Medicines Regulation. In the medicolegal field, Professor O'Grady was formerly HM Coroner and specialises in drug-induced injury and malpractice in relation to drugs as well as patent and intellectual property issues in relation to medical products. |
| Ian Dodds-Smith graduated in law from Downing College, Cambridge, qualified as a solicitor at McKenna & Co. and later became a partner in 1984. He is now head of the Life Sciences Group in the merged firm, Cameron McKenna and head of the healthcare group - a sub-group specialising in regulatory, research and product liability issues concerning the pharmaceutical and chemical sectors. The Group has conducted several cases concerning national licensing issues for pharmaceutical companies with a number resulting in references to the European Court, including two relating to the scope of abridged applications. It co-ordinates such litigation for clients across the EU. His appointments include Consultant Editor of the Personal and Medical Injuries Law Letter, Member of the Editorial Board of the Regulatory Affairs Journal and various Royal College and Medical Research Council Working Parties on research issues. He is a Fellow of the Royal Society of Medicine and Member of the Drug Information Association and Federation of Insurance & Corporate Counsel. He has written widely on regulatory and product liability issues. |
| Nigel Walsh is a Consultant Pharmaceutical Physician. After serving in the RAMC, he worked as a principal in general practice in England and Australia for 15 years before becoming Medical Director, Parke Davis and Co. UK and then Medical Director, International Medical Affairs, Warner Lambert Company in the USA. For the last 12 years he has worked independently as a pharmaceutical physician and is a founder of the Medical Expert Partnership specialising in drug-induced injury and medical negligence. |
| Michael Spencer was called to the bar in 1970, having read law at Oxford University. Most of his practice has been in the medical field, specialising in group litigation, particularly that relating to pharmaceutical products, and in medical negligence. He became a Crown Court Recorder in 1987, Queen's Counsel in 1989 and a Master of the Bench of the Inner Temple in 1996. |
|
